Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
2008
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Reversible Natural Language Watermarking Using Synonym Substitution and Arithmetic Coding
2018
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-β Activation and Cell Infiltration
2008
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Osteoporosis
2006
Protein-bound molybdenum cofactor is bioavailable and rescues molybdenum cofactor-deficient C. elegans
2021 StandoutNobel
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Characterization of an Epithelial ∼460-kDa Protein That Facilitates Endocytosis of Intrinsic Factor-Vitamin B12 and Binds Receptor-associated Protein
1997
Relationship between age, renal function and bone mineral density in the US population
2003
Vertebral Fracture Assessment: The 2005 ISCD Official Positions
2006
Preventing fractures in elderly people
2003
Renal albumin absorption in physiology and pathology
2006
Balancing Acts
2004 Standout
The roles of cubilin and megalin, two multiligand receptors, in proximal tubule function: possible implication in the progression of renal disease
2001
Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension
2004
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
2004
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
2007
Osteoporosis: now and the future
2011 Standout
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study
2002
The Effect of Raloxifene Treatment in Postmenopausal Women with CKD
2008
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
2004
Skeletal remodeling in health and disease
2007 Standout
Treatment of postmenopausal osteoporosis
2002
Denosumab in Postmenopausal Women with Low Bone Mineral Density
2006
Current options for the management of postmenopausal osteoporosis
2011
Ankylosing spondylitis
2007 Standout
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
2007
Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery
2003
Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease
2006
Distribution of mRNA coding for Alpha-2-macroglobulin, the murinoglobulins, the Alpha-2-macroglobulin receptor and the Alpha-2-macroglobulin receptor associated protein during mouse embryogenesis and in adult tissues
1994
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
Bone metabolism in male patients with type 2 diabetes
2005
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Determinants of hyperkyphosis in patients with ankylosing spondylitis
2005
Epidemiology of Vertebral Fractures
2015
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
2003
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women
2010
The endocytic receptor megalin binds the iron transporting neutrophil‐gelatinase‐associated lipocalin with high affinity and mediates its cellular uptake
2004
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein
1999
The Intrinsic Factor-Vitamin B12 Receptor and Target of Teratogenic Antibodies Is a Megalin-binding Peripheral Membrane Protein with Homology to Developmental Proteins
1998
Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
2009
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Cross-Scale Coefficient Selection for Volumetric Medical Image Fusion
2012
Bisphosphonate treatment of osteoporosis
2003
Prevention of falls and consequent injuries in elderly people
2005 Standout
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
2012
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Efficacy and Safety of Oral Weekly Ibandronate in the Treatment of Postmenopausal Osteoporosis
2003
HoxGroup 3 Paralogs Regulate the Development and Migration of the Thymus, Thyroid, and Parathyroid Glands
1998 StandoutNobel
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club
2005
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Rapid Detection of Rice Disease Based on FCM-KM and Faster R-CNN Fusion
2019 Standout
Experimental production of congenital malformations in strains of inbred mice by maternal treatment with hypervitaminosis A.
1961
Cell Biology of the Glomerular Podocyte
2003 Standout
Multiple histograms based reversible data hiding by using FCM clustering
2019
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes
2007 Standout
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2004
Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule
2001
Signals for Sorting of Transmembrane Proteins to Endosomes and Lysosomes
2003 Standout
Interventions for enhancing medication adherence
2008 Standout
Thyroid Function within the Upper Normal Range Is Associated with Reduced Bone Mineral Density and an Increased Risk of Nonvertebral Fractures in Healthy Euthyroid Postmenopausal Women
2010
Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia
2001
Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study
2005
Two-Year Results of Once-Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis
2002
Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
2005
Pixel-level image fusion: A survey of the state of the art
2016 Standout
Defective forebrain development in mice lacking gp330/megalin.
1996 Standout
Emerging drugs for postmenopausal osteoporosis
2009
Interventions for enhancing medication adherence
2014 Standout
GP330 is specifically expressed in outer cells during epithelial differentiation in the preimplantation mouse embryo
1994
Siderophore-Based Iron Acquisition and Pathogen Control
2007 Standout
Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence
2023 Standout
Deep Learning for Predictive Analytics in Reversible Steganography
2023
Convergence of blockchain and artificial intelligence in IoT network for the sustainable smart city
2020 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2005
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients
2001
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
2016 StandoutNobel
The amazing osteocyte
2010 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Ibandronate: A Comparison of Oral Daily Dosing Versus Intermittent Dosing in Postmenopausal Osteoporosis
2001
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
2008
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Retinoic Acid Embryopathy
1985 Standout
Algorithm-Based Qualitative and Semiquantitative Identification of Prevalent Vertebral Fracture: Agreement Between Different Readers, Imaging Modalities, and Diagnostic Approaches
2007
Works of C. Roux being referenced
First demonstration of the efficacy of an anti-osteoporotic treatment in very elderly osteoporotic women.
2004
Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS)
2007
Clinical evaluation of spine morphometric X-ray absorptiometry
1998
Comparison of Four Morphometric Definitions and a Semiquantitative Consensus Reading for Assessing Prevalent Vertebral Fractures
2001
Information fusion, application to data and model fusion for ultrasound image segmentation
1999
Comparative immunochemistry and ontogeny of two closely related coated pit proteins. The 280-kd target of teratogenic antibodies and the 330-kd target of nephritogenic antibodies.
1993
Antibodies to the 280-kd coated pit protein, target of teratogenic antibodies, produce alterations in the traffic of internalized proteins.
1994
Coexpression in humans by kidney and fetal envelopes of a 280 kDa-coated pit-restricted protein. Similarity with the murine target of teratogenic antibodies.
1992
Reversible Watermarking Based on Invariant Image Classification and Dynamic Histogram Shifting
2012
Osteoporosis, body composition, and bone turnover in ankylosing spondylitis.
1999
Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
2000
[Experimental uretero-hydronephrosis caused by hypervitaminosis A in the embryo].
1958